SCNC phenotypic convergence reveals shared vulnerabilities

Abstract

Balanis, Sheu and colleagues show that small-cell neuroendocrine cancers converge on a common molecular phenotype across epithelial tissues and share therapeutic vulnerabilities with haematological cancers, revealing unique opportunities to guide the development of new treatments based on existing blood cancer therapies.